A Phase II Trial of Temozolomide for Patients with Recurrent or Progressive Brain Metastases
- 1 January 2001
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 53 (3), 259-265
- https://doi.org/10.1023/a:1012226718323
Abstract
Background: Treatment options for patients with recurrent brain metastases are extremely limited. This study was designed to determine the safety and efficacy of temozolomide in the treatment of...Keywords
This publication has 13 references indexed in Scilit:
- Phase II study of temozolomide in heavily pretreated cancer patients with brain metastasesAnnals of Oncology, 2001
- Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.1999
- The Role of Hyperfractionated Re-irradiation in Metastatic Brain DiseaseAmerican Journal of Clinical Oncology, 1997
- TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors.1997
- Recurrent brain metastases.1996
- Reoperation for recurrent metastatic brain tumorsJournal of Neurosurgery, 1995
- The treatment of patients with recurrent brain metastases. A retrospective analysis of 109 patients with nonsmall cell lung cancerCancer, 1995
- Stereotactic Radiosurgery for the Definitive, Noninvasive Treatment of Brain MetastasesJNCI Journal of the National Cancer Institute, 1995
- The role of radiation therapy in the treatment of brain metastasesInternational Journal of Radiation Oncology*Biology*Physics, 1992
- One-Sample Multiple Testing Procedure for Phase II Clinical TrialsBiometrics, 1982